Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick T Gunning

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|March 1, 2020
Optimization of a high-throughput fluorescence polarization assay for STAT5B DNA binding domain-targeting inhibitorsPimyupa Manaswiyoungkul, Fettah Erdogan, Olasunkanmi O Olaoye, et al.
Current Pharmaceutical Design|November 16, 2012
Targeting the ubiquitin E1 as a novel anti-cancer strategyWei Xu, Julie L Lukkarila, Sara R da Silva, et al.
Leukemia|May 6, 2018
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancerBettina Wingelhofer, Heidi A Neubauer, Peter Valent, et al.
Plos One|August 12, 2016
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- ActivityKatja Linher-Melville, Mina G Nashed, Robert G Ungard, et al.
Exploration of Targeted Anti-Tumor Therapy|September 15, 2023
Medicinal chemistry advances in targeting class I histone deacetylasesDiaaeldin I Abdallah, Elvin D de Araujo, Naman H Patel, et al.
Expert Opinion on Therapeutic Patents|September 24, 2015
A STAT inhibitor patent review: progress since 2011Ping-Shan Lai, David A Rosa, Ahmed Magdy Ali, et al.
Journal of Medicinal Chemistry|December 7, 2023
Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular DystrophyYasir S Raouf, Abootaleb Sedighi, Mulu Geletu, et al.
Inorganic Chemistry|July 13, 2012
Phosphopeptide selective coordination complexes as promising SRC homology 2 domain mimeticsJoel A Drewry, Eugenia Duodu, Amir Mazouchi, et al.
Expert Opinion on Therapeutic Targets|November 18, 2017
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomasAnna Orlova, Bettina Wingelhofer, Heidi A Neubauer, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|April 16, 2019
Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cellsMulu Geletu, Zaid Taha, Rozanne Arulanandam, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Pharmaceutical and Biomedical Analysis|March 1, 2020
Optimization of a high-throughput fluorescence polarization assay for STAT5B DNA binding domain-targeting inhibitorsPimyupa Manaswiyoungkul, Fettah Erdogan, Olasunkanmi O Olaoye, et al.
Current Pharmaceutical Design|November 16, 2012
Targeting the ubiquitin E1 as a novel anti-cancer strategyWei Xu, Julie L Lukkarila, Sara R da Silva, et al.
Leukemia|May 6, 2018
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancerBettina Wingelhofer, Heidi A Neubauer, Peter Valent, et al.
Plos One|August 12, 2016
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- ActivityKatja Linher-Melville, Mina G Nashed, Robert G Ungard, et al.
Exploration of Targeted Anti-Tumor Therapy|September 15, 2023
Medicinal chemistry advances in targeting class I histone deacetylasesDiaaeldin I Abdallah, Elvin D de Araujo, Naman H Patel, et al.
Expert Opinion on Therapeutic Patents|September 24, 2015
A STAT inhibitor patent review: progress since 2011Ping-Shan Lai, David A Rosa, Ahmed Magdy Ali, et al.
Journal of Medicinal Chemistry|December 7, 2023
Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular DystrophyYasir S Raouf, Abootaleb Sedighi, Mulu Geletu, et al.
Inorganic Chemistry|July 13, 2012
Phosphopeptide selective coordination complexes as promising SRC homology 2 domain mimeticsJoel A Drewry, Eugenia Duodu, Amir Mazouchi, et al.
Expert Opinion on Therapeutic Targets|November 18, 2017
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomasAnna Orlova, Bettina Wingelhofer, Heidi A Neubauer, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|April 16, 2019
Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cellsMulu Geletu, Zaid Taha, Rozanne Arulanandam, et al.
Pageof 10